Skip to content

Supernus Pharmaceuticals SUPN Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
$9.33M+24.9%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$20.01M-14.1%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
4.9%0.0pp
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$55.8M+13.5%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$46.27M-8.6%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$1.86M-13.9%

Other financials

Income statement

See full
Revenue$207.7M+38.6%
Gross profit$184.3M+37.5%
Operating income-$8.3M+18.8%
Net income-$2.3M+80.6%
EPS (diluted)-$0.04+81.0%

Balance sheet

See full
Cash & equivalents$186.3M+60.8%
Total debt$40.9M+26.6%
Total equity$1.1B+4.5%
Total assets$1.5B+11.4%

Cash flow

See full
Operating cash flow$66.5M+117%
CapEx--100%
Free cash flow$66.5M+120%

Valuation

See full
Market cap$2.58B+62.8%
Enterprise value$2.44B+62.3%
P/S3.3×+0.9×

Profitability

See full
Gross margin89.4%+1.0pp
Operating margin-7.8%-18.9pp
Net margin-3.7%-13.0pp
FCF margin27.9%+3.4pp

Returns & leverage

See full
Return on equity-2.8%-9.1pp
Debt / equity0.0×
Current ratio-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization.

The official record: Supernus Pharmaceuticals’s 10-Q, filed November 5, 2021, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Supernus Pharmaceuticals's operating lease ROU assets?
Supernus Pharmaceuticals (SUPN) reported operating lease ROU assets of $0 in Q3 2021.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.